Literature DB >> 30199100

Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma.

J J Yu1,2, F Shen1, T H Chen3, L Liang1, J Han1, H Xing1, Y H Zhou4, H Wang5, W M Gu6, W Y Lau1,7, T Yang1.   

Abstract

BACKGROUND: Whether preoperative bodyweight is associated with long-term prognosis in patients after liver resection for hepatocellular carcinoma (HCC) is controversial. This study aimed to investigate the relationship of patient weight with long-term recurrence and overall survival (OS) after curative liver resection for HCC.
METHODS: Data for patients with HCC who underwent curative liver resection between 2000 and 2015 in five centres in China were analysed retrospectively in three groups according to their preoperative BMI: underweight (BMI 18·4 kg/m2 or less), normal weight (BMI 18·5-24·9 kg/m2 ) and overweight (BMI 25·0 kg/m2 or above). Patients' baseline characteristics, operative variables and long-term survival outcomes were compared. Univariable and multivariable Cox regression analyses were performed to identify risk factors for OS and recurrence-free survival (RFS) after resection.
RESULTS: Of 1524 patients, 107 (7·0 per cent) were underweight, 891 (58·5 per cent) were of normal weight and 526 (34·5 per cent) were overweight. Univariable analyses showed that underweight and overweight patients had poorer OS (both P < 0·001) and RFS (both P < 0·001) than patients of normal weight. Multivariable Cox regression analysis also identified both underweight and overweight to be independent risk factors for OS (hazard ratio (HR) 1·22, 95 per cent c.i. 1·19 to 1·56, P = 0·019; and HR 1·57, 1·36 to 1·81, P < 0·001, respectively) and RFS (HR 1·28, 1·16 to 1·53, P = 0·028; and HR 1·34, 1·17 to 1·54, P < 0·001).
CONCLUSION: Underweight and overweight patients appear to have a worse prognosis than those of normal weight following liver resection for HCC.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 30199100     DOI: 10.1002/bjs.10981

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

Review 1.  Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.

Authors:  Daniel Geh; Derek M Manas; Helen L Reeves
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 8.265

2.  A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.

Authors:  Li-Yang Sun; Hong Zhu; Yong-Kang Diao; Hao Xing; Lei Liang; Jie Li; Ya-Hao Zhou; Wei-Min Gu; Ting-Hao Chen; Yong-Yi Zeng; Timothy M Pawlik; Wan Yee Lau; Chao Li; Feng Shen; Cheng-Wu Zhang; Tian Yang
Journal:  Ann Transl Med       Date:  2020-12

3.  Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients.

Authors:  Chang-Zhi Chen; Jian-Hong Zhong; Ya-Peng Qi; Jie Zhang; Tao Huang; Liang Ma; Le-Qun Li; Tao Peng; Bang-De Xiang
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

4.  Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).

Authors:  Lei Liang; Ming-Da Wang; Yao-Ming Zhang; Wan-Guang Zhang; Cheng-Wu Zhang; Wan Yee Lau; Feng Shen; Timothy M Pawlik; Dong-Sheng Huang; Tian Yang
Journal:  J Hepatocell Carcinoma       Date:  2021-03-12

5.  Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study.

Authors:  Jia-Le Pu; Zhong Chen; Lan-Qing Yao; Ji-Ye Feng; Yong-Kang Diao; Ming-Cheng Guan; Ju-Dong Li; Zheng-Liang Chen; Ya-Hao Zhou; Hong Wang; Wei-Min Gu; Jie Li; Chao Li; Ming-Da Wang; Hong Zhu; Ying-Jian Liang; Feng Shen; Timothy M Pawlik; Wan Yee Lau; Tian Yang
Journal:  BJS Open       Date:  2022-01-06

6.  A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.

Authors:  Shu-Wen Zhang; Ning-Ning Zhang; Wen-Wen Zhu; Tian Liu; Jia-Yu Lv; Wen-Tao Jiang; Ya-Min Zhang; Tian-Qiang Song; Li Zhang; Yan Xie; Yong-He Zhou; Wei Lu
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.